TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. The company provides BRIUMVI, an anti-CD20 monoclonal antibody for the...
8 insider purchases on record · latest filing 2023-08-14.
Insiders have also filed 47 sale transactions at TGTX.